Li Hongbo, Yang Zihan, Huang Jingbo, Lin Lele, Shi Dike, Chu Yiming, Wu Dan, Cai Yanna, Li Baozhong, Lu Junyang, Guo Qingqu
Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, China.
Department of Gastroenterology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, China.
Sci Rep. 2025 Apr 7;15(1):11826. doi: 10.1038/s41598-025-96310-1.
This study investigates the role of CALCR, a G-protein-coupled receptor, in gastric cancer (GC) progression and its interaction with ANTXR1. A total of 121 patients with gastric cancer were enrolled from the Department of General Surgery, Anyang Tumor Hospital, Anyang City, Henan Province, China. 218 tumor tissues and corresponding para-carcinoma tissues were collected from 109 patients, while adjacent tissues were retained from the remaining 12 cases. Kaplan-Meier analysis evaluated the prognostic value of m6A-related genes in GC. Immunohistochemistry (IHC) was conducted to evaluate CALCR expression. Quantitative real-time PCR (qRT-PCR), Western blot analysis, CCK-8 assays, flow cytometry and transwell assays were used to assess CALCR's role in cell proliferation, apoptosis, migration, and invasion. Co-immunoprecipitation experiments were performed to explore the interaction between CALCR and ANTXR1. Statistical analyses were conducted using SPSS 25.0 and GraphPad Prism 8.0, with p < 0.05 considered significant. IHC staining revealed that 53.2% (n = 58) of the tumor tissues exhibited high CALCR expression, compared to only 6.6% (n = 8) of the para-carcinoma tissues (p < 0.001). CALCR knockdown in GC cell lines significantly reduced proliferation (p < 0.01), increased apoptosis (p < 0.01), and inhibited migration and invasion (p < 0.001). In a nude mouse model, CALCR knockdown resulted in significantly reduced tumor growth and metastasis (p < 0.05). Co-immunoprecipitation showed that CALCR interacts with ANTXR1, leading to decreased AKT phosphorylation. CALCR is a crucial factor in GC progression, presenting a potential prognostic marker and therapeutic target. Targeting the CALCR-ANTXR1 axis and AKT pathway offers new avenues for GC treatment.
本研究调查了G蛋白偶联受体CALCR在胃癌(GC)进展中的作用及其与ANTXR1的相互作用。共从中国河南省安阳市肿瘤医院普通外科招募了121例胃癌患者。从109例患者中收集了218份肿瘤组织及相应的癌旁组织,其余12例保留了相邻组织。采用Kaplan-Meier分析评估m6A相关基因在GC中的预后价值。进行免疫组织化学(IHC)以评估CALCR表达。采用定量实时PCR(qRT-PCR)、蛋白质免疫印迹分析、CCK-8检测、流式细胞术和Transwell检测来评估CALCR在细胞增殖、凋亡、迁移和侵袭中的作用。进行免疫共沉淀实验以探索CALCR与ANTXR1之间的相互作用。使用SPSS 25.0和GraphPad Prism 8.0进行统计分析,p < 0.05被认为具有统计学意义。IHC染色显示,53.2%(n = 58)的肿瘤组织呈现高CALCR表达,而癌旁组织中只有6.6%(n = 8)呈现高表达(p < 0.001)。GC细胞系中CALCR基因敲低显著降低了增殖(p < 0.01),增加了凋亡(p < 0.01),并抑制了迁移和侵袭(p < 0.001)。在裸鼠模型中,CALCR基因敲低导致肿瘤生长和转移显著减少(p < 0.05)。免疫共沉淀显示CALCR与ANTXR1相互作用,导致AKT磷酸化降低。CALCR是GC进展中的关键因素,是一种潜在的预后标志物和治疗靶点。靶向CALCR-ANTXR1轴和AKT途径为GC治疗提供了新途径。